DeutschNewstral
Article
The Times of India on 2021-10-26 20:02
Covaxin approval: WHO seeks additional clarifications for final 'risk-benefit assessment'
Related news
- WHO decision on Covaxin approval likely soonThe Times of India
WHO’s approval for Covaxin likely this monthThe Hindu- India-made Covaxin gets WHO approval, can be used globallyThe Times of India
- BCovaxin: Concern over 'rushed' approval for India Covid jabbbc.co.uk
- Covishield, Covaxin to get full approval but won’t be retailingThe Times of India
- 'Bharat Biotech yet to apply for Covaxin approval by Canada'The Times of India
- 'Delay in WHO approval for Covaxin a serious setback for India'The Times of India
- Regular market approval granted for Covishield, Covaxin for use in adult populationThe Hindu
- Coronavirus live updates | Govt reviews process to get WHO approval for CovaxinThe Hindu
- Coronavirus | Central panel recommends approval for CovaxinThe Hindu
- WHO's approval for Covaxin likely this monthThe Times of India
- Coronavirus | After SII, Bharat Biotech seeks DCGI approval for CovaxinThe Hindu
- Diwali gift to India: Covaxin gets WHO approvalThe Times of India
- Scientists divided over restricted use approval for CovaxinThe Hindu
- Covaxin: Government reviews process to get WHO approvalThe Hindu
- Decision on Covaxin nod likely in 4-6 weeks: WHOThe Hindu
- Australia recognises CovaxinThe Times of India
- Coronavirus | Covaxin gets central drugs authority panel approval for restricted useThe Hindu
- Covaxin: Expert panel recommends emergency use approval for 2-18 year oldsThe Hindu